Huimei Wu

Dr. Huimei Wu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2023 in Frontiers in Endocrinology
Verified
Journal Article
Open access
ZYZhaoyang Yu
Zhaoyang Yu
WPWeilong Peng
Weilong Peng
FLFeiwen Li
Feiwen Li
XFXiaoqian Fu
Xiaoqian Fu
JWJiajia Wang
Jiajia Wang
HWHuimei Wu
Huimei Wu
Background: The metabolic characteristics of premature ovarian insufficiency (POI), a reproductive endocrine disease characterized by abnormal sex hormone metabolism and follicle depletion, remain unclear. Metabolomics is a powerful tool for exploring disease phenotypes and biomarkers. This study aims to identify metabolic markers and construct diagnostic models, and elucidate the underlying pathological mechanisms for POI.Methods: Non-targeted metabolomics was utilized to characterize the plasma metabolic profile of 40 patients. The metabolic markers were identified through bioinformatics and machine learning, and constructed an optimal diagnostic model by classified multi-model analysis. Enzyme-linked immunosorbent assay (ELISA) was used to verify antioxidant indexes, mitochondrial enzyme complexes, and ATP levels. Finally, integrated transcriptomics and metabolomics were used to reveal the dysregulated pathways and molecular regulatory mechanisms of POI.Results: The study identified eight metabolic markers significantly correlated with ovarian reserve function. The XGBoost diagnostic model was developed based on six machine learning models, demonstrating its robust diagnostic performance and clinical applicability through the evaluation of receiver operating characteristic (ROC) curve, decision curve analysis (DCA), calibration curve, and precise recall (PR) curve. Multi-omics analysis showed that mitochondrial respiratory chain electron carrier (CoQ10) and enzyme complex subunits were down-regulated in POI. ELISA validation revealed an elevation in oxidative stress markers and a reduction in the activities of antioxidant enzymes, CoQ10, and mitochondrial enzyme complexes in POI.Conclusion: Our findings highlight that mitochondrial dysfunction and energy metabolism disorders are closely related to the pathogenesis of POI. The identification of metabolic markers and predictive models holds significant implications for the diagnosis, treatment, and monitoring of POI.

14 February 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZYZhaoyang Yu
Zhaoyang Yu
XZXiqian Zhang
Xiqian Zhang
YNYingqi Nong
Yingqi Nong
HDHongfan Ding
Hongfan Ding
XFXiaoqian Fu
Xiaoqian Fu
FLFenghua Liu
Fenghua Liu
Premature ovarian insufficiency (POI) is a reproductive endocrine disorder characterized by infertility and the perimenopausal syndrome. Its genetic etiology is highly heterogeneous and not yet fully understood. Limited by short-read sequencing, the profile and structural variation of the full-length transcript for POI have remained elusive. Therefore, this study included peripheral blood samples from 5 POI patients and 5 controls, characterizing full-length transcripts of POI using Oxford Nanopore sequencing firstly. Ultimately, we identified 26,122 transcripts, including 7,724 novel gene loci and 13,593 novel transcripts. A total of 382 differentially expressed transcripts were identified, including 366 down-regulated and 16 up-regulated transcripts. Based on transcript structure variant analysis, 8,834 alternative splicing events, 65,254 alternative polyadenylation sites and 32 motifs were further identified, revealing the diversity sources of transcript isoforms, proteins and genetic complexity. Enrichment analysis of differentially AS genes suggested that the ferroptosis pathway may play an important role in the pathogenesis of POI.Additionally, 494 high-confidence lncRNAs, 1,768 transcription factors, and novel gene-coding regions were predicted based on full-length transcript sequence. Analysis of immune cell subtypes revealed the expression of CD8 + T cells and monocytes were down-regulated in POI, which was significantly positively correlated with AMH, suggesting that CD8 + T cells and monocytes could serve as potential diagnostic markers and immunotherapy targets for POI. Conclusively, this study provides new perspectives on the pathogenesis, post-transcriptional regulation mechanisms, and immune targets of POI.

5 February 2026 in International Journal of Surgery
Verified
Journal Article
Open access
ZYZhaoyang Yu
Zhaoyang Yu
MFMeie Fang
Meie Fang
MLMujun Li
Mujun Li
FLFeiwen Li
Feiwen Li
TZTao Zhang
Tao Zhang
HWHuimei Wu
Huimei Wu
Background: Premature ovarian insufficiency (POI) is characterized by gonadotropin elevation, estrogen deficiency, and follicular loss. Resveratrol (RSV), a natural polyphenol with antioxidant and anti-aging properties, shows therapeutic promise for POI, but its molecular targets and mechanisms remain unclear. Methods: Network pharmacology analysis was used to identify overlapping targets of RSV and POI, followed by Gene Ontology (GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, protein–protein interaction (PPI) network construction, and hub gene screening. Molecular docking and dynamics simulations were performed to characterize the affinity and binding stability. In vivo , a cyclophosphamide-induced POI rat model was established to evaluate the protective effects of RSV on ovarian morphology and hormone levels. In vitro , a 4-hydroperoxycyclophosphamide-induced granulosa cell model was used to assess DNA damage and homologous recombination (HR) activity through TUNEL staining, Western blotting, and nuclear foci analysis, with RAD51 inhibition applied to verify pathway dependence. Results: About 609 overlapping genes between RSV- and POI-related targets were identified. GO and KEGG enrichment analyses revealed significant involvement in reproductive system development, DNA repair complex, and cellular senescence. PPI and topological analysis identified three core genes – ATM, BRCA1, and RAD51 – significantly enriched in the HR pathway. Molecular docking and dynamic simulations indicate that RSV has a strong affinity and stable binding mode with these three targets. In vivo , RSV ameliorated cyclophosphamide-induced ovarian injury, increasing serum anti-Müllerian hormone levels and secondary follicle counts. Mechanistically, in the POI cell model, RSV upregulated RAD51 and downregulated γH2AX expression, thereby promoting HR pathway activation and DNA double-strand break repair. The protective effect of RSV was abolished by the RAD51 inhibitor RI-1. Immunofluorescence foci analysis further verified that RSV enhanced the recruitment of RAD51 to DNA damage sites and reduced nuclear γH2AX accumulation. Conclusion: This study provides structural and experimental evidence for the target selection, structural optimization, and molecular mechanism of RSV in the treatment of POI.

24 September 2026 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
ZYZhaoyang Yu
Zhaoyang Yu
LLLidan Liu
Lidan Liu
XZXiqian Zhang
Xiqian Zhang
YLYing Li
Ying Li
YNYingqi Nong
Yingqi Nong
FLFenghua Liu
Fenghua Liu
Background: Cyclophosphamide (CTX)-induced chemotherapy injury is a leading iatrogenic cause of premature ovarian insufficiency (POI) and a major barrier to fertility preservation. Yet the systems-level mechanisms underlying its reproductive toxicity remain poorly defined. Methods: An integrated network toxicology framework incorporating machine learning and Mendelian randomization (MR) was applied to identify candidate targets, evaluate genetic associations, and establish a predictive model. Ovarian transcriptomic and metabolomic profiling, together with in vivo validation, were subsequently performed in a CTX-induced POI rat model. Single-cell-based in silico perturbation analysis was further conducted to investigate the potential cellular functions and mechanisms of key candidate targets in POI. Results: Integrated bioinformatic analyses and machine learning prioritized six candidate targets associated with CTX-induced ovarian injury, with PLS regression consistently identified as the optimal predictive model. SHAP analysis revealed CXCL1 and COL4A4 as the major contributors to model prediction. MR supported genetic associations between genetically predicted CXCL1/COL4A4 expression and POI risk. Immunohistochemical validation confirmed protein expression patterns consistent with transcriptomic findings. Multi-omics profiling revealed a convergent ovarian injury signature characterized by impaired cell-cycle regulation (G2/M checkpoint), defective DNA damage repair and mitotic function (mitotic spindle), enhanced apoptotic signaling, and coordinated suppression of folate metabolism, ubiquinone biosynthesis, and cytochrome P450-mediated drug metabolism pathways. Single-cell-based in silico perturbation analysis further suggested that CXCL1 and COL4A4 may contribute to ovarian dysfunction through regulation of inflammatory responses and extracellular matrix remodeling. Conclusion: This study shows that CTX-induced ovarian injury is accompanied by coordinated alterations in immune-inflammatory signaling, cell-cycle and DNA damage responses, and metabolic homeostasis. CXCL1 and COL4A4 were prioritized as candidate biomarkers associated with POI risk, providing potential targets for further mechanistic investigation and fertility-preserving interventions.